Listed

Janux Therapeutics, Inc.

JANXNasdaqCIK 1817713HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$10.3m, Q2 FY2026
Operating income−$31.7m, Q2 FY2026
Net income−$22.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m2.5Revenue, Q3 FY2023, three months to 2023-09-30$2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure2.5Revenue, Q4 FY2023, three months to 2023-12-31$2.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure1.3Revenue, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure8.9Revenue, Q2 FY2024, three months to 2024-06-30$8.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure0.4Revenue, Q3 FY2024, three months to 2024-09-30$439.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure10.0Revenue, Q3 FY2025, three months to 2025-09-30$10.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure3.7Revenue, Q1 FY2026, three months to 2026-03-31$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure10.3Revenue, Q2 FY2026, three months to 2026-06-30$10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Research and development$m11.9Research and development, Q3 FY2023, three months to 2023-09-30$11.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure12.2Research and development, Q4 FY2023, three months to 2023-12-31$12.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure14.1Research and development, Q1 FY2024, three months to 2024-03-31$14.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure14.9Research and development, Q2 FY2024, three months to 2024-06-30$14.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure18.6Research and development, Q3 FY2024, three months to 2024-09-30$18.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure20.8Research and development, Q4 FY2024, three months to 2024-12-31$20.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure25.1Research and development, Q1 FY2025, three months to 2025-03-31$25.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure34.7Research and development, Q2 FY2025, three months to 2025-06-30$34.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure34.6Research and development, Q3 FY2025, three months to 2025-09-30$34.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure31.5Research and development, Q4 FY2025, three months to 2025-12-31$31.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure26.8Research and development, Q1 FY2026, three months to 2026-03-31$26.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure31.0Research and development, Q2 FY2026, three months to 2026-06-30$31.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Operating income$m(15.8)Operating income, Q3 FY2023, three months to 2023-09-30−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure(16.1)Operating income, Q4 FY2023, three months to 2023-12-31−$16.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure(20.2)Operating income, Q1 FY2024, three months to 2024-03-31−$20.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure(13.8)Operating income, Q2 FY2024, three months to 2024-06-30−$13.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure(35.8)Operating income, Q3 FY2024, three months to 2024-09-30−$35.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure(29.0)Operating income, Q4 FY2024, three months to 2024-12-31−$29.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure(34.9)Operating income, Q1 FY2025, three months to 2025-03-31−$34.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure(45.1)Operating income, Q2 FY2025, three months to 2025-06-30−$45.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure(35.3)Operating income, Q3 FY2025, three months to 2025-09-30−$35.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure(42.4)Operating income, Q4 FY2025, three months to 2025-12-31−$42.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure(34.2)Operating income, Q1 FY2026, three months to 2026-03-31−$34.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure(31.7)Operating income, Q2 FY2026, three months to 2026-06-30−$31.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Net income$m(11.6)Net income, Q3 FY2023, three months to 2023-09-30−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure(11.8)Net income, Q4 FY2023, three months to 2023-12-31−$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure(14.8)Net income, Q1 FY2024, three months to 2024-03-31−$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure(6.0)Net income, Q2 FY2024, three months to 2024-06-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure(28.1)Net income, Q3 FY2024, three months to 2024-09-30−$28.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure(20.2)Net income, Q4 FY2024, three months to 2024-12-31−$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure(23.5)Net income, Q1 FY2025, three months to 2025-03-31−$23.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure(33.9)Net income, Q2 FY2025, three months to 2025-06-30−$33.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure(24.3)Net income, Q3 FY2025, three months to 2025-09-30−$24.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure(31.9)Net income, Q4 FY2025, three months to 2025-12-31−$31.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure(24.4)Net income, Q1 FY2026, three months to 2026-03-31−$24.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure(22.0)Net income, Q2 FY2026, three months to 2026-06-30−$22.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Diluted EPS$ per share(0.25)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figurenot reported(0.30)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure(0.11)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure(0.51)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figurenot reported(0.38)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure(0.55)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure(0.39)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figurenot reported(0.39)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure(0.35)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Basic EPS$ per share(0.25)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figurenot reported(0.30)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure(0.11)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure(0.51)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figurenot reported(0.38)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure(0.55)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure(0.39)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figurenot reported(0.39)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure(0.35)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure

Balance sheet

Cash and equivalents$27.8m, Q2 FY2026
Shareholders' equity$928.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m17.2Cash and equivalents, Q3 FY2023, at 2023-09-30$17.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0000950170-23-060288.Report this figure19.2Cash and equivalents, FY2023, at 2023-12-31$19.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0000950170-25-029177.Report this figure213Cash and equivalents, Q1 FY2024, at 2024-03-31$212.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0000950170-24-054966.Report this figure14.7Cash and equivalents, Q2 FY2024, at 2024-06-30$14.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0000950170-24-092857.Report this figure26.8Cash and equivalents, Q3 FY2024, at 2024-09-30$26.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure431Cash and equivalents, FY2024, at 2024-12-31$430.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-076918.Report this figure73.7Cash and equivalents, Q1 FY2025, at 2025-03-31$73.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure52.4Cash and equivalents, Q2 FY2025, at 2025-06-30$52.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure48.4Cash and equivalents, Q3 FY2025, at 2025-09-30$48.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure52.3Cash and equivalents, FY2025, at 2025-12-31$52.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure51.8Cash and equivalents, Q1 FY2026, at 2026-03-31$51.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure27.8Cash and equivalents, Q2 FY2026, at 2026-06-30$27.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Current assets$m355Current assets, Q3 FY2023, at 2023-09-30$355.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060288.Report this figure349Current assets, FY2023, at 2023-12-31$349.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029177.Report this figure659Current assets, Q1 FY2024, at 2024-03-31$658.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-054966.Report this figure662Current assets, Q2 FY2024, at 2024-06-30$661.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092857.Report this figure666Current assets, Q3 FY2024, at 2024-09-30$666.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure1,034Current assets, FY2024, at 2024-12-31$1.03bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076918.Report this figure1,023Current assets, Q1 FY2025, at 2025-03-31$1.02bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure1,006Current assets, Q2 FY2025, at 2025-06-30$1.01bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure998Current assets, Q3 FY2025, at 2025-09-30$998.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure976Current assets, FY2025, at 2025-12-31$975.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure1,002Current assets, Q1 FY2026, at 2026-03-31$1.00bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure983Current assets, Q2 FY2026, at 2026-06-30$983.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Total assets$m387Total assets, Q3 FY2023, at 2023-09-30$386.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-060288.Report this figure380Total assets, FY2023, at 2023-12-31$380.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-029177.Report this figure689Total assets, Q1 FY2024, at 2024-03-31$689.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-054966.Report this figure691Total assets, Q2 FY2024, at 2024-06-30$691.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000950170-24-092857.Report this figure695Total assets, Q3 FY2024, at 2024-09-30$695.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure1,062Total assets, FY2024, at 2024-12-31$1.06bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-076918.Report this figure1,051Total assets, Q1 FY2025, at 2025-03-31$1.05bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure1,032Total assets, Q2 FY2025, at 2025-06-30$1.03bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure1,025Total assets, Q3 FY2025, at 2025-09-30$1.02bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure1,002Total assets, FY2025, at 2025-12-31$1.00bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure1,028Total assets, Q1 FY2026, at 2026-03-31$1.03bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure1,008Total assets, Q2 FY2026, at 2026-06-30$1.01bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Current liabilities$m14.5Current liabilities, Q3 FY2023, at 2023-09-30$14.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060288.Report this figure13.0Current liabilities, FY2023, at 2023-12-31$13.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029177.Report this figure10.6Current liabilities, Q1 FY2024, at 2024-03-31$10.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-054966.Report this figure11.5Current liabilities, Q2 FY2024, at 2024-06-30$11.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092857.Report this figure17.2Current liabilities, Q3 FY2024, at 2024-09-30$17.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure17.5Current liabilities, FY2024, at 2024-12-31$17.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001193125-26-076918.Report this figure17.5Current liabilities, Q1 FY2025, at 2025-03-31$17.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure21.4Current liabilities, Q2 FY2025, at 2025-06-30$21.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure27.8Current liabilities, Q3 FY2025, at 2025-09-30$27.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure25.0Current liabilities, FY2025, at 2025-12-31$25.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure58.9Current liabilities, Q1 FY2026, at 2026-03-31$58.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure60.2Current liabilities, Q2 FY2026, at 2026-06-30$60.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Total liabilities$m37.9Total liabilities, Q3 FY2023, at 2023-09-30$37.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-060288.Report this figure36.1Total liabilities, FY2023, at 2023-12-31$36.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-029177.Report this figure33.2Total liabilities, Q1 FY2024, at 2024-03-31$33.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-054966.Report this figure33.7Total liabilities, Q2 FY2024, at 2024-06-30$33.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0000950170-24-092857.Report this figure38.9Total liabilities, Q3 FY2024, at 2024-09-30$38.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure38.7Total liabilities, FY2024, at 2024-12-31$38.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-076918.Report this figure38.3Total liabilities, Q1 FY2025, at 2025-03-31$38.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure41.7Total liabilities, Q2 FY2025, at 2025-06-30$41.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure48.2Total liabilities, Q3 FY2025, at 2025-09-30$48.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure44.7Total liabilities, FY2025, at 2025-12-31$44.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure86.7Total liabilities, Q1 FY2026, at 2026-03-31$86.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure79.7Total liabilities, Q2 FY2026, at 2026-06-30$79.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure
Shareholders' equity$m349Shareholders' equity, Q3 FY2023, at 2023-09-30$348.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure344Shareholders' equity, FY2023, at 2023-12-31$344.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-076918.Report this figure656Shareholders' equity, Q1 FY2024, at 2024-03-31$655.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure658Shareholders' equity, Q2 FY2024, at 2024-06-30$657.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure656Shareholders' equity, Q3 FY2024, at 2024-09-30$656.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure1,023Shareholders' equity, FY2024, at 2024-12-31$1.02bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure1,012Shareholders' equity, Q1 FY2025, at 2025-03-31$1.01bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure991Shareholders' equity, Q2 FY2025, at 2025-06-30$990.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure977Shareholders' equity, Q3 FY2025, at 2025-09-30$976.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure957Shareholders' equity, FY2025, at 2025-12-31$956.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure942Shareholders' equity, Q1 FY2026, at 2026-03-31$941.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure928Shareholders' equity, Q2 FY2026, at 2026-06-30$928.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure

Cash flow

Operating cash flow$12.5m, Q2 FY2026
Capital expenditure$202.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(11.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0000950170-24-122370. Derived: 9-month figure less the 6-month figure.Report this figure(9.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure(14.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure(10.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$10.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105069. Derived: 6-month figure less the 3-month figure.Report this figure(2.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269799. Derived: 9-month figure less the 6-month figure.Report this figure(16.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$16.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure(17.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure(23.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$23.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338078. Derived: 6-month figure less the 3-month figure.Report this figure(12.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$12.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269799. Derived: 9-month figure less the 6-month figure.Report this figure(28.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$28.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure(12.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure12.5Operating cash flow, Q2 FY2026, three months to 2026-06-30$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-338078. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$470.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0000950170-24-122370. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2023, three months to 2023-12-31$515.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$197.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$95.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105069. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$25.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269799. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2025, three months to 2025-03-31$371.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure0.5Capital expenditure, Q2 FY2025, three months to 2025-06-30$473.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338078. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$93.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269799. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$106.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076918. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2026, three months to 2026-03-31$273.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$202.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-338078. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)62.94m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares41.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3041,526,524 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000950170-23-060288.Report this figure41.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3141,763,971 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0000950170-24-054966.Report this figure41.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3041,836,238 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000950170-24-092857.Report this figure45.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3045,708,649 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0000950170-24-122370.Report this figure49.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3149,049,741 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-067083.Report this figure54.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3054,451,666 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105069.Report this figure54.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3054,628,670 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure61.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3161,791,721 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure61.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3061,902,411 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure62.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3062,023,685 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269799.Report this figure62.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3162,665,717 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212146.Report this figure62.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3062,937,295 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure

Shares outstanding: 61.14mShares outstanding, period not labelled, at 2026-08-0461,136,773 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-338078.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.